Ryan’s early research career has focused on understanding the pathophysiology of secondary degeneration following neurotrauma to the central nervous system. Ryan looks to help develop new techniques to provide a more accurate diagnosis and prognosis of spinal cord injury, to identify potential treatment strategies in a clinical setting.
Mr. Tran obtained his BS degree in Chemical Engineering from Hochiminh University of Industry (Vietnam) in 2014, and the MS degree in Nanoscience from Gachon University (South Korea) in 2016. From September 2016 to December 2016, he was a Research Associate at Gachon Bionano Research Institute - a leading Biological & Nanotechnology research institute in South Korea. His research was focused on three-dimensional graphene-metal oxide hybrid hydrogel as high performance materials for energy and environmental applications.
We are using the latest genome engineering techiques to introduce human Alzheimer's disease mutations into our experimental model, the zebrafish. We then study these mutant zebrafish using "deep sequencing" analysis of gene expression to observe how the mutations change the molecular state of cells in their brains.
Joanne completed her PhD in 2007 at the University of Sydney. She began her postdoctoral training at the Heart Research Institute where she explored the vascular protective effects of high-density lipoproteins. Joanne joined the SAHMRI in January 2017 where she leads the miRNAs and Diabetes research programs in the Heart Health Theme. Her current research interests include exploring novel therapeutic targets that will alleviate vascular complications associated with diabetes.
Professor Helen Winefield and Dr. Peter Strelan are the supervisors of my PhD, the focus of which is on students aged 17-20 years in their first year of university, who have relocated to Adelaide. Most of such students come either from abroad or from regional and remote areas of Australia, and have just entered the 'Emerging Adult' period of their lives.
I am a lecturer in the School of Public Health. My teaching mainly focuses on health promotion, and I am co-coordinator of the Honours program in the school. Additionally, I am co-coordinator the 3rd year Internship course. I am currently co-supervising one honours and one PhD student.
Acute Lymphoblastic Leukaemia (ALL) is an extremely heterogeneous disease with subtypes of patients exhibiting a diverse range of genetic mutations. Certain subtypes of ALL can be treated with drugs already in clinical use. Laura undertook her Fulbright fellowship (2016-2017) at St. Jude Children’s Research Hospital in Memphis, Tennessee where she learned mouse models of high-risk ALL. She also investigated the functional significance of mutations to the transcription factor MYB, which have recently been identified in T-ALL patients.